Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Christine Castro, Neil Rothstein, Jonathan Ward

Premium

Direct-to-consumer genetic testing firm 23andMe has announced several new appointments to its executive team. Christine Castro has been appointed vice president of communications, Neil Rothstein as VP of marketing, and Jonathan Ward as VP of strategic alliances.

Before joining 23andMe, Castro was VP of corporate relations at Genentech, chief communications officer for Yahoo!, and VP of corporate communications at the Walt Disney Company.

Rothstein worked at Netflix for 11 years before coming to 23andMe. Most recently, he served as VP of online marketing at Netflix.

Ward was interim chief marketing officer at eHarmony.com before coming to 23andMe. He has held marketing and business development positions at America Online, McKinsey & Company, as well as Ogilvy, Adams & Rinehart.

The Scan

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.

Coronary Artery Disease Risk Loci, Candidate Genes Identified in GWAS Meta-Analysis

A GWAS in Nature Genetics of nearly 1.4 million coronary artery disease cases and controls focused in on more than 200 candidate causal genes, including the cell motility-related myosin gene MYO9B.

Multiple Sclerosis Contributors Found in Proteome-Wide Association Study

With a combination of genome-wide association and brain proteome data, researchers in the Annals of Clinical and Translational Neurology tracked down dozens of potential multiple sclerosis risk proteins.

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.